Covid Drug 80 Times More Potent Than Trump’s Tested in Italy

0 1

Source: Bloomberg

Give Iftar and Sahur this Ramadan

Feeding the poor and needy is an act that draws us closer to Allah. We earn His forgiveness, mercies and blessings through this act of charity.

“Whoever gives food to a fasting person with which to break his fast will have a reward equal to his, without it detracting in the slightest from the reward of the fasting person” Al-Tirmidhi




By Chiara Albanese and Flavia Rotondi March 6, 2021, 12:00 AM EST




  •  Siena’s single-shot antibody therapy could cut bottlenecks
  •  Pharma hub development could be part of push for production

Tucked in the Tuscan hills around Siena in Italy, a research lab has come up with an antibody treatment for Covid-19 that its developers say will be 80 times more potent than the one given to former U.S. President Donald Trump in his most critical days in hospital last year.




The therapy is derived from the blood of people who’ve recovered from Covid, and relies on 453 different antibodies. It will also be administered as a single shot rather than a drawn-out infusion, which has been the norm for similar drugs. Clinical trials of about 3,000 doses produced so far started in Italy Thursday, and a roll out for general use could be approved as early as this summer.




“The focus of our work has been on dosage,” said Fabrizio Landi, president of the Toscana Life Sciences Foundation, the promoter of the project. “When Trump received an antibodies drug he had to have an hours-long infusion. We are aiming at getting to a dose 80 times more powerful than the one he got.”

Support Islam Religion Guardian
At the present time, we are running on very limited funds. In order for us to run Islam Religion Guardian service efficiently, we are in need of your generous support.




Read further

Subscribe to our newsletter
Sign up here to get the latest news, updates delivered directly to your inbox.
You can unsubscribe at any time

Leave A Reply

Your email address will not be published.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy